These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 22358096)
1. Effects of bestatin on phagocytic cells in cyclophosphamide-treated mice. Lis M; Obmińska-Mrukowicz B Pharmacol Rep; 2011; 63(6):1481-90. PubMed ID: 22358096 [TBL] [Abstract][Full Text] [Related]
2. The effects of bestatin on humoral response to sheep erythrocytes in non-treated and cyclophosphamide-immunocompromised mice. Lis M; Szczypka M; Suszko A; Obmińska-Mrukowicz B Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):133-8. PubMed ID: 22957713 [TBL] [Abstract][Full Text] [Related]
3. Clomipramine, a tricyclic antidepressant, and selegiline, a monoamine oxidase-B inhibitor, modulate the activity of phagocytic cells after oral administration in mice. Sobieszczańska A; Lis M; Suszko-Pawłowska A; Szczypka M J Pharm Pharmacol; 2020 Jun; 72(6):836-842. PubMed ID: 32144951 [TBL] [Abstract][Full Text] [Related]
4. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems. Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322 [TBL] [Abstract][Full Text] [Related]
5. The effects of selective and nonselective phosphodiesterase inhibitors on phagocytic cells in mice. Szczypka M; Obmińska-Mrukowicz B Immunopharmacol Immunotoxicol; 2010 Sep; 32(3):507-13. PubMed ID: 20136387 [TBL] [Abstract][Full Text] [Related]
6. Effects of bestatin on myelopoietic stem cells in normal and cyclophosphamide-treated mice. Abe F; Matsuda A; Schneider M; Talmadge JE Cancer Immunol Immunother; 1990; 32(2):75-80. PubMed ID: 2289207 [TBL] [Abstract][Full Text] [Related]
7. Leukemic cell-surface CD13/aminopeptidase N and resistance to apoptosis mediated by endothelial cells. Mishima Y; Matsumoto-Mishima Y; Terui Y; Katsuyama M; Yamada M; Mori M; Ishizaka Y; Ikeda K; Watanabe J; Mizunuma N; Hayasawa H; Hatake K J Natl Cancer Inst; 2002 Jul; 94(13):1020-8. PubMed ID: 12096087 [TBL] [Abstract][Full Text] [Related]
8. Hematopoietic and therapeutic properties of bestatin in normal and myelosuppressed mice. Talmadge JE; Pelus LM; Black PL; Abe F Biomed Pharmacother; 1991; 45(2-3):61-9. PubMed ID: 1912371 [TBL] [Abstract][Full Text] [Related]
9. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes. Schorlemmer HU; Bosslet K; Sedlacek HH Cancer Res; 1983 Sep; 43(9):4148-53. PubMed ID: 6871856 [TBL] [Abstract][Full Text] [Related]
10. Effect of bestatin on in vitro responses of murine lymphocytes to T-cell stimuli. Dunlap BE; Dunlap SA; Rich DH Scand J Immunol; 1984 Sep; 20(3):237-45. PubMed ID: 6238401 [TBL] [Abstract][Full Text] [Related]
11. Hematopoietic and hematologic properties of bestatin in normal and cyclophosphamide myelosuppressed mice. Talmadge JE; Black PL; Pelus LM; Abe F Biomed Pharmacother; 1990; 44(2):85-91. PubMed ID: 2224059 [TBL] [Abstract][Full Text] [Related]
12. Protective effects of bestatin in the retina of streptozotocin-induced diabetic mice. Hossain A; Heron D; Davenport I; Huckaba T; Graves R; Mandal T; Muniruzzaman S; Wang S; Bhattacharjee PS Exp Eye Res; 2016 Aug; 149():100-106. PubMed ID: 27344955 [TBL] [Abstract][Full Text] [Related]
13. Effect of ubenimex (Bestatin) on the cell growth and phenotype of HL-60 and HL-60R cell lines: up-and down-regulation of CD13/aminopeptidase N. Imamura N; Kimura A Leuk Lymphoma; 2000 May; 37(5-6):663-7. PubMed ID: 11042531 [TBL] [Abstract][Full Text] [Related]
14. Bestatin, an inhibitor for aminopeptidases, modulates the production of cytokines and chemokines by activated monocytes and macrophages. Lkhagvaa B; Tani K; Sato K; Toyoda Y; Suzuka C; Sone S Cytokine; 2008 Dec; 44(3):386-91. PubMed ID: 19036603 [TBL] [Abstract][Full Text] [Related]
15. Influence of bestatin, an inhibitor of aminopeptidases, on T and B lymphocyte subsets in mice. Lis M; Szczypka M; Suszko A; Obmińska-Mrukowicz B Pol J Vet Sci; 2011; 14(3):393-403. PubMed ID: 21957733 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of human endometrial stromal decidualization by bestatin, an aminopeptidase-N inhibitor. Tanaka T; Umesaki N; Masuda M; Mizuno K; Ogita S Gynecol Endocrinol; 2000 Jun; 14(3):182-6. PubMed ID: 10923279 [TBL] [Abstract][Full Text] [Related]
17. Effect of irradiation, cyclophosphamide, and etoposide (VP-16) on number of peripheral blood and peritoneal leukocytes in mice under normal conditions and during acute inflammatory reaction. van't Wout JW; Linde I; Leijh PC; van Furth R Inflammation; 1989 Feb; 13(1):1-14. PubMed ID: 2921082 [TBL] [Abstract][Full Text] [Related]
18. LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin. Gao JJ; Gao ZH; Zhao CR; Yuan Y; Cui SX; Zhang XF; Cheng YN; Xu WF; Tang W; Qu XJ Invest New Drugs; 2011 Aug; 29(4):574-82. PubMed ID: 20111888 [TBL] [Abstract][Full Text] [Related]
19. Bestatin-induced enhancement of in vivo phagocytosis determined by a new simple assay. Peschke T; Recknagel RD; Veckenstedt A; Baumgart J; Werner W Allerg Immunol (Leipz); 1991; 37(3-4):125-9. PubMed ID: 1793085 [TBL] [Abstract][Full Text] [Related]
20. Nutritionally relevant concentrations of resveratrol and hydroxytyrosol mitigate oxidative burst of human granulocytes and monocytes and the production of pro-inflammatory mediators in LPS-stimulated RAW 264.7 macrophages. Bigagli E; Cinci L; Paccosi S; Parenti A; D'Ambrosio M; Luceri C Int Immunopharmacol; 2017 Feb; 43():147-155. PubMed ID: 27998828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]